Summary
Atrial premature beats are frequently diagnosed during pregnancy (PR), supraventricular tachycardia (SVT) (atrial tachycardia, AV nodal reentrant tachycardia, circus movement tachycardia) less frequently. For acute therapy, electrical cardioversion with 50–100 Joules is indicated in all unstable patients (pts). In stable SVT the initial therapy includes vagal maneuvers to terminate breakthrough tachycardias. For short-term management, when vagal maneuvers fail, intravenous adenosine is the first choice drug and may safely terminate the arrhythmia. Ventricular premature beats are also frequently present during PR and benign in most pts; however, malignant ventricular tachyarrhythmias (sustained ventricular tachycardia [VT], ventricular flutter [VFlut], ventricular fibrillation [VF]) were observed less frequently. Electrical cardioversion is necessary in all pts with a hemodynamically unstable situation and life-threatening ventricular tachyarrhythmias; in hemodynamically stable pts, initial therapy with ajmaline, procainamide or lidocaine is indicated. In pts with syncopal VT, VF, VFlut or aborted sudden death an implantable cardioverter-defibrillator is indicated. In pts with symptomatic bradycardia, a pacemaker can be implanted using echocardiography at any stage of PR. The treatment of the pregnant patient with cardiac arrhythmias requires important modification of the standard practice of arrhythmia management. The goal of therapy is to protect the patient and fetus through delivery, after which chronic or definitive therapy can be admininstered.
Zusammenfassung
Supraventrikuläre Extrasystolen werden während einer Schwangerschaft (SWS) häufig beobachtet, supraventrikuläre Tachykardien (atriale Tachykardien, AV-Knoten-Reentry-Tachykardien, „circus-movement“ Tachykardien) dagegen eher seltener. Zur Akut-Therapie (AT) ist bei hämodynamischer Instabilität (HI) eine elektrische Kardioversion (KV) mit 50–100 Joules notwendig. Bei stabiler Hämodynamik (SH) sollten primär vagale Maneuver durchgeführt werden, bei Versagen vagaler Maßnahmen ist Adenosin das Medikament der 1. Wahl. Ventrikuläre Extrasystolen sind während einer SWS ebenfalls relativ häufig und bei den meisten Patientinnen (Pt) harmlos, maligne ventrikuläre Arrhythmien (ventrikuläre Tachykardien [KT], Kammerflattern [KFlat], Kammerflimmern [KF]) werden dagegen selten beobachtet. Als AT sollte bei HI eine elektrische KV erfolgen, bei SH kommen Ajmalin, Procainamid oder Lidocain in Betracht. Für Pt mit synkopaler KT, KF, KFlat oder überlebtem plötzlichen Tod ist der implantierbare Defibrillator eine therapeutische Alternative. Bei Pt mit symptomatischen Bradykardien kann unter Echokontrolle ein Schrittmacher-System in jedem Stadium der SWS implantiert werden. Trotz notwendiger Besonderheiten im therapeutischen Verhalten während einer SWS können alle supraventrikulären und/oder ventrikulären Arrhythmien adäquat behandelt werden und bei sorgfältiger Beachtung von Risiken, Nebenwirkungen und Komplikationen aller therapeutischen Maßnahmen können auch komplizierte Schwangerschaften erfolgreich beendet werden.
Similar content being viewed by others
References
Anderer G, Hellmeyer L, Tekesin I, Schmidt S (2005) Kombinationstherapie einer fetalen supraventrikulären Tachykardie mit Flecainid und Digoxin. Z Geburtshilfe Neonatol 209:34–37
Balmer C, Fasnacht MS, Rahn M, Molinari L, Bauersfeld U (2002) Long-term follow-up of children with complete atrioventricular block and impact of pacemaker therapy. Europace 4:345–349
Barron WM, Mujais SK, Zinamam M, Bravo EL, Lindheimer MD (1986) Plasma catecholamine responses to physiologic stimuli in normal human pregnancy. Am J Obstet Gynecol 154:80–84
Bravermann AC, Bromley BS, Rutherford JD (1991) New onset ventricular tachycardia during pregnancy. Int J Cardiol 33:409–412
Briggs GG, Freeman RK, Yaffe SJ (1998) Drugs in pregnancy and lactation. Williams & Wilkins, 5th Ed, Baltimore
Brodsky M, Doria R, Allen B, Sato D, Thomas G, Sada M (1992) New-onset ventricular tachycardia during pregnancy. Am Heart J 123:933–941
Cardosi RJ, Chez RA (1998) Magnesium sulfate, maternal hypothermia, and fetal bradycardia with loss of heart rate variability. Obstet Gynecol 92:691–693
Chow T, Galvin J, McGowern B (1998) Antiarrhythmic drug therapy in pregnancy and lactation. Am J Cardiol 82:58I–62I
Cleary-Goldmann J, Salva CR, Infeld JI, Robinson JN (2003) Verapamil-sensitive idiopathic left ventricular tachycardia in pregnancy. J Matern Fetal Neonatal Med 14:132–135
Copel JA, Kleiman CS (1989) Fetal echocardiography in the diagnosis and management of fetal heart disease. Clin Diagn Ultrasound 25:67–83
Cox JL, Gardner MJ (1993) Treatment of cardiac arrhythmias during pregnancy. Prog Cardiovasc Dis 36:137–178
Crosson JE, Scheel JN (1996) Fetal arrhythmias: diagnosis, and current recommendations for therapy. Progress in Pediatric Cardiology 5:141–147
Curry JJ, Quintana FJ (1970) Myocardial infarction with ventricular fibrillation during pregnancy treated by direct current defibrillation with fetal survival. Chest 58:82–84
Dalvi BV, Chaudhuri A, Kulkarni HL, Purushottam KA (1992) Therapeutic guidelines for congenital heart block presenting in pregnancy. Obstet Gynecol 79:802-804
Danielsson BR, Azarbayjani F, Skold AC, Webster WS (1997) Initiation of phenytoin teratogenesis: pharmacologically induced embryonic bradycardia and arrhythmia resulting in hypoxia and possible free radical damage at reoxygenation. Teratology 56:271–281
DeSilva RA, Graboys TB, Podrid PJ, Lown B (1980) Cardioversion and defibrillation. Am Heart J 100:881–895
Dominguez A, Iturralde P, Hermosillo AG, Colin L, Kershenovich S, Garrido LM (1999) Successful radiofrequency ablation of an accessory pathway during pregnancy. Pacing Clin Electrophysiol 22:131–134
Facchini M, Bauersfeld U, Fasnacht M, Candinas R (2000) Mütterliche Herzrhythmusstörungen während der Schwangerschaft. Schweiz Med Wochenschr 130:1962–1969
Fasnacht MS, Günthard J (2004) Fetale Kardiologie beinhaltet nicht nur fetale Echokardiographie. Pediatrica 15:27–29
Fasnacht MS, Jaeggi E (2001) Pränatale und genetische Aspekte angeborener Herzfehler. Therapeutische Umschau 58:70–75
Ferrero S, Colombo BM, Ragni N (2004) Maternal arrhythmias during pregnancy. Arch Gynecol Obstet 269:244–253
Finlay AY, Edmunds V (1979) DC cardioversion in pregnancy. Br J Clin Pract 33:88–94
Fouron JC, Fournier A, Proulx F, Lamarche J, Bigras JL, Boutin C, Brassard M, Gamache S (2003) Management of fetal tachyarrhythmias based on superior vena cava/aorta Doppler flow recordings. Heart 89:1211–1216
Gembruch U, Hansmann M, Bald R (1988) Direct intrauterine fetal treatment of fetal tachyarrhythmia with severe hydrops fetalis by antiarrhythmic drugs. Fetal Ther 3:210–215
Gembruch U, Hansmann M, Redel DA, Bald R (1988) Intrauterine therapy of fetal tachyarrhythmias: intraperitoneal administration of antiarrhythmic drugs to the fetus in fetal tachyarrhythmias with severe hydrops fetalis. J Perinat Med 16:39–44
Gembruch U, Manz M, Bald R, Ruddel H, Redel DA, Schlebusch H, Nitsch J, Hansmann M (1989) Repeated intravascular treatment with amiodarone in a fetus with refractory supraventricular tachycardia and hydrops fetalis. Am Heart J 118:1335–1338
Gowda RM, Khan IA, Mehta NJ, Vasavada BC, Sacchi TJ (2003) Cardiac arrhythmias in pregnancy: clinical and therapeutic considerations. Int J Cardiol 88:129–133
Gras D, Mabo P, Kermarrec A, Bazin P, Varin C, Daubert C (1992) Radiofrequency ablation of atrioventricular conduction during the 5th month of pregnancy. Arch Mal Coeur Vaiss 85:1873–1877
Grosso S, Bernardi R, Cioni M, Morgese G (1998) Transient neonatal hypothyoidism after gestational exposure to amiodarone: a follow-up of two cases. J Endocrinol Invest 21:699–702
Habib A, McCarthy JS (1977) Effects on the neonate of propranolol admininstered during pregnancy. J Pediatr 91:808–811
Heinroth K, Knitza R, Werdan K (2003) Schwangerschaft. In: Werdan K, Trappe HJ, Zerkowski HR (Hrsg) Das Herzbuch. Urban & Fischer, München-Jena, 882–891
Hohnloser SH, Meinertz T, Zehender M, Geibel A, Just H (1988) Auslösung und Verstärkung von Herzrhythmusstörungen durch Antiarrhythmika. Internist 29:338–344
Huang H, Lin Q, Zhang L (1997) Clinical observation of cardiac pacemaker in pregnant women. Chuang Hua Fu Chan Ko Tsa Chih 32:345–346
Hubinont C, Debauche C, Bernard P, Sluysmans T (1998) Resolution of fetal tachycardia and hydrops by a single adenosine administration. Obstet Gynecol 92:718–720
Isaacs JD, Mulholland DH, Hess LW, Albert JR, Martin RW (1993) Pregnancy in a woman with an automatic implantable cardioverter defibrillator: a case report. J Reprod Med 36:487–488
Ishii K, Chiba Y, Sasaki Y, Kawamata K, Miyashita S (2003) Fetal atrial tachycardia diagnosed by magnetocardiography and direct fetal electrocardiography. A case report of treatment with propranolol hydrochloride. Fetal Diagn Ther 18:463–466
Jaeggi E, Fouron JC, Drblik SP (1998) Fetal atrial flutter: diagnosis, clinical features, treatment, and outcome. J Pediatr 132:335–339
Joglar JA, Page RL (1999) Treatment of cardiac arrhythmias during pregnancy: safety considerations. Drug Saf 20:85–94
Khositseth A, Ramin KD, O’Leary PW, Porter CJ (2003) Role of amiodarone in the treatment of fetal supraventricular tachyarrhythmias and hydrops fetalis. Pediatr Cardiol 24:454–456
Klein HH, Pich S (2003) Physiologische Änderungen des Herz-Kreislauf-Systems in der Schwangerschaft. Herz 28:173–174
Krapp M, Kohl T, Simpson JM, Sharland GK, Katalinic A, Gembruch U (2003) Heart 89:913–917
Lau CP, Lee CP, Wong CK, Cheng CH, Leung WH (1990) Rate responsive pacing with a minute ventilation sensing pacemaker during pregnancy and delivery. Pacing Clin Electrophysiol 13:158–163
Lee SH, Chen SA, Wu TJ, Chiang CE, Cheng CC, Tai CT, Chiou CW, Ueng KC, Chang MS (1995) Effects of pregnancy on first onset and symptoms of paroxysmal supraventricular tachycardia. Am J Cardiol 76:675–678
Machado MVL, Tynan M, Curry PVL, Allen LD (1988) Fetal complete heart block. Br Heart J 56:512–515
Magee LA, Downar E, Sermer M, Boulton BC, Allen LC, Koren G (1995) Pregnancy outcome after gestational exposure to amiodarone in Canada. Am J Obstet Gynecol 172:1307–1311
Magee LA, Nulman I, Rovet JF, Koren G (2000) Risks and benefits of betareceptor blockers for pregnancy hypertension: overview of the randomized trials. Eur J Obstet Gynecol Reprod Biol 88:15–26
Maulik D (1989) Basic principles of Doppler ultrasound as applied in obstetrics. Clin Obstet Gynecol 32:628–644
McAnulty JH, Morton MJ, Ueland K (1988) The heart and pregnancy. Curr Probl Cardiol 13:589–665
McBridge WG (1961) Thalodomide and congenital abnormalities. Lancet 28:1358–1364
McCurdy CM Jr, Rutherford SE, Coddington CC (1993) Syncope and sudden arrhythmic death complicating pregnancy, A casde report of Romano-Ward syndrome. J Reprod Med 38:233–234
Mendelson CL (1956) Disorders of the heartbeat during pregnancy. Am J Obstet Gynecol 72:1268–1270
Mitani GM, Steinberg I, Lien EJ, Harrison EC, Elkayam U (1987) The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation. Clin Pharmacokinet 12:253-291
Mozo de Rosales F, Moreno J, Bodegas A, Melchor JC, Fernandez Lebrez L, Aranguren G (1994) Conversion of atrial fibrillation with ajmaline in a pregnant woman with Wolff-Parkinson-White syndrome. Eur J Obstet Gynecol 56:63–66
Nagel BHP, Neudorf U, Hanssler L, Kuhn U, Schmaltz AA (2000) Therapeutische Optionen bei fetaler Tachyarrhythmie (Problems of therapy of fetal life-threatening dysrhythmias). Monatsschr Kinderheilkd 148:666–672
Nakagawa M, Katou S, Ichinose M, Nobe S, Yonemochi H, Miyakawa I, Saikawa T (2004) Characteristics of new-onset ventricular arrhythmias in pregnancy. J Electrocardiol 37:47–53
Natale A, Davidson T, Geiger MJ, Newby K (1997) Implantable cardioverter-defibrillators and pregnancy. A safe combination? Circulation 96:2808–2812
Navarro V, Nathan PE, Rosero H, Sacchi TJ (1993) Accelerated idioventricular rhythm in pregnancy: a case report. Angiology 44:506–508
Ogburn PL Jr, Schmidt G, Linman J, Cefalo RC (1982) Paroxysmal tachycardia and cardioversion during pregnancy. J Reprod Med 27:359–362
Pagdad SV, Barmade AB, Toal SC, Vora AM, Lokhandwala YY (2004) “Rescue” radiofrequency ablation for atrial tachycardia presenting as cardiomyopathy in pregnancy. Indian Heart J 56:245–247
Page RL (1995) Treatment of arrhythmias during pregnancy. Am Heart J 130:871–876
Page RL, Shenasa H, Evans J, Sorrentino RA, Wharton JM, Prystowsky EN (1993) Radiofrequency catheter ablation of idiopathic recurrent ventricular tachycardia with a right bundle branch block, left axis pattern. Pace Clin Electrophysiol 16:327–336
Piper JM, Berkus M, Ridgway LE (1992) Pregnancy complicated by chronic cardiomyopathy and an automatic implantable cardioverter defibrillator. Am J Obstet Gynecol 167:506–507
Plomp TA, Vulsma T, de Vijlder JJ (1992) Use of amiodarone during pregnancy. Eur J Obstet Gynecol Reprod Biol 43:201–207
Rahilly GT, Prystowsky EN, Zipes DP, Nacarelli GV, Jackman WM, Heger JJ (1982) Clinical and electrophysiologic findings in patients with repetitive monomorphic ventricular tachycardia and otherwise normal electrocardiogram. Am J Cardiol 50:459–468
Ramsewak S, Persad P, Perkins S, Narayansingh G (1992) Twin pregnancy in a patient with complete heart block. A case report. Clin Exp Obstet Gynecol 19:166–167
Rotmensch HH, Elkayam U, Frishman W (1983) Antiarrhythmic drug therapy during pregnancy. Ann Intern Med 98:487–497
Sager PT, Bhandari AK. Narrow complex tachycardias. Differential diagnosis and management (1991) In: Shah PK (Hrsg) Cardiology Clinics—acute cardiac care. WB Saunders Company, Philadelphia, S 619–640
Schaefer C, Spielmann H (2001) Arzneiverordnung in Schwangerschaft und Stillzeit. Urban & Fischer, München Jena:2–26
Schuster HP, Trappe HJ (2005) EKG-Kurs für Isabel. Thieme, Stuttgart, 4. Auflage, 1–314
Sermer M, Colman J, Siu S (2003) Pregnancy complicated by heart disease: a review of Canadian experience. J Obstet Gynaecol 23:540–544
Shotan A, Ostrzega E, Mehra A, Johnson JV, Elkayam U (1997) Incidence of arrhythmias in normal pregnancy and relation to palpitations, dizziness, and syncope. Am J Cardiol 79:1061–1064
Speranza G, Verlato G, Albiero A (1998) Autonomic changes during pregnancy: assessment by spectral heart rate variability analysis. J Electro Cardiol 31:101–109
Tan HL, Lie KI (2001) Treatment of tachyarrhythmias during pregnancy and lactation. Eur Heart J 22:458–464
Task Force Members, Oakley C, Child A, Iung B et al (2003) Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J 24:761–781
Tawam M, Levine J, Mendelson M, Goldberger J, Dyer A, Kadish A (1993) Effect of pregnancy on paroxysmal supraventricular tachycardia. Am J Cardiol 72:838–840
Trappe HJ (1996) Therapie von Herzrhythmusstörungen ohne Antiarrhythmika. Möglichkeiten und Indikationen. In: Gerok W, Hartmann F, Pfreundschuh M, Philipp T, Schuster HP, Sybrecht GW (Hrsg) Klinik der Gegenwart. Urban & Schwarzenberg, München, 14:1–25
Trappe HJ (1997) Akuttherapie supraventrikulärer Tachykardien: Adenosin oder Ajmalin? Intensivmed 34:452–461
Trappe HJ, Schuster HP (2000) Brugada-Syndrom. Definition, Diagnostik, Therapie, Prognose. Intensivmed 37:680–687
Trappe HJ (2001) Amiodaron. Intensivmed 38:169–178
Varon ME, Sherer DM, Abramowicz JS, Akiyama T (1992) Maternal ventricular tachycardia associated with hypomagnesemia. Am J Obstet Gynecol 167:1352–1355
Vaughan Williams EM (1984) A classification of antiarrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol 24:129–147
Wada H, Chiba Y, Murakami M, Kawaguchi H, Kobayashi H, Kanzaki T (1996) Analysis of maternal and fetal risk in 594 pregnancies with heart disease. Nippon Sanka Fujinka Gakkai Zasshi 48:255–262
Walsh KA, Erzi MD, Denes P (1988) Emergency treatment of tachyarrhythmias. Med Clin North Am 70:791–811
Wellens HJJ, Conover MB (1992) The ECG in emergency decision making. WB Saunders Company, Philadelphia, New York
Widerhorn J, Widerhorn ALM, Rahimtoola SH, Elkayam U (1992) WPW syndrome during pregnancy: increased incidence of supraventricular arrhythmias. Am Heart J 123:796–798
Wilson JD (1977) Embryotoxicity of drugs to man. In: Wilson JD, Frazer FC (Hrsg) Handbook of teratology. Plenum Press, New York: 309–355
Wolbrette D (2003) Treatment of arrhythmias during pregnancy. Curr Womens Health Rep 3:135–139
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Trappe, HJ. Akuttherapie mütterlicher und kindlicher Rhythmusstörungen während der Schwangerschaft. Intensivmed 42, 671–682 (2005). https://doi.org/10.1007/s00390-005-0624-7
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00390-005-0624-7
Key words
- Cardiac arrhythmias
- pregnancy
- sudden death
- automatic implantable cardioverter defibrillator
- antiarrhythmic drugs